US 9150514
Dual-acting antihypertensive agents
granted A61KA61K31/415A61K31/4164
Quick answer
US patent 9150514 (Dual-acting antihypertensive agents) held by Theravance Biopharma R&D IP, LLC expires Mon Oct 01 2035 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Theravance Biopharma R&D IP, LLC
- Grant date
- Tue Oct 06 2015 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Oct 01 2035 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 26
- CPC classes
- A61K, A61K31/415, A61K31/4164, A61K31/417, A61K31/4188